Skip to main content
Rohtesh Mehta, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

RohteshSMehtaMD

Oncology Houston, TX

Hematologic Oncology, Hospice & Palliative

Physician

Dr. Mehta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mehta's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hospice and Palliative Medicine, 2009 - 2010
  • Mercy Catholic Medical Center
    Mercy Catholic Medical CenterResidency, Internal Medicine, 2006 - 2009
  • Government Medical College Patiala
    Government Medical College PatialaClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • TX State Medical License
    TX State Medical License 2016 - 2024
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • MN State Medical License
    MN State Medical License 2015 - 2017
  • PA State Medical License
    PA State Medical License 2006 - 2014
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
    Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

  • Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
    Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...
    Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients
    Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Guest Editorial: Advances in Immunotherapy for Hematological Malignancies
    Guest Editorial: Advances in Immunotherapy for Hematological MalignanciesFebruary 9th, 2018

Professional Memberships

Hospital Affiliations